IMARC Group, a leading market research company, has recently releases report titled “G-Protein Coupled Receptors (GPCRs) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032″, The study provides a detailed analysis of the industry, including the global G-protein coupled receptors (GPCRs) market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the G-protein coupled receptors (GPCRs) market?
The global G-protein coupled receptors (GPCRs) market size reached US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.69% during 2024-2032.
G-protein coupled receptors (GPCRs) transmit signals from extracellular stimuli to the interior of the cell, thus influencing a wide range of physiological processes. It involves the binding of ligands, such as hormones, neurotransmitters, or drugs, to the receptor located on the cell surface. This binding initiates a cascade of intracellular events by activating specific G-proteins, which act as intermediaries in transmitting the signal to downstream effectors. One of the major advantages of GPCRs is their involvement in diverse biological processes, making them attractive targets for therapeutic interventions. They regulate various functions, including sensory perception, neurotransmission, immune responses, and hormone regulation. Currently, there are different types of product variants classified into several families based on sequence homology and functional characteristics, including rhodopsin-like receptors, secretin-like receptors, metabotropic glutamate receptors, and adhesion-like receptors.
Request for a PDF sample of this report: https://www.imarcgroup.com/g-protein-coupled-receptors-market/requestsample
G-Protein Coupled Receptors (GPCRs) Market Trends:
The global G-Protein coupled receptors (GPCRs) market is primarily bolstered by the increasing prevalence of chronic diseases, such as cardiovascular disorders, cancer, and neurological disorders. Moreover, the burgeoning investments by pharmaceutical companies in research and development (R&D) activities and the advancements in technology have facilitated the identification and characterization of novel GPCR targets, which is another factor supporting the market growth. Furthermore, the escalating prevalence of lifestyle-related disorders, such as obesity and diabetes, has driven the demand for drugs targeting GPCRs involved in metabolic regulation, which is accelerating the market growth. Other factors, such as the growing geriatric population, the surging need for more effective and safer treatments for conditions, such as Alzheimer’s disease and macular degeneration, and favorable government initiatives and supportive regulatory frameworks are influencing the market growth.
G-Protein Coupled Receptors (GPCRs) Market 2024-2032 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the G-Protein coupled receptors (GPCRs) market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abcam plc
- Becton Dickinson and Company
- Enzo Biochem Inc.
- Eurofins DiscoverX Products LLC
- HD Biosciences Co. Ltd. (WuXi AppTec)
- Merck KGaA
- Molecular Devices LLC (Danaher Corporation)
- PerkinElmer Inc.
- Promega Corporation
- Thermo Fisher Scientific Inc
Key Market Segmentation:
The report has segmented the global G-Protein coupled receptors (GPCRs) market based on product type, assay type, application and region.
Breakup by Product type:
- Cell Lines
- Detection Kits
- Cell Culture Reagents
- Ligands
Breakup by Assay Type:
- cAMP Functional Assays
- Calcium Functional Assays
- β-Arrestin Functional Assays
- Radioligand Binding and GTPγS Functional Assays
- Internalization Assays
- Trafficking Assays
- Others
Breakup by Application:
- Cancer Research
- CNS Research
- Metabolic Research
- Cardiovascular Research
- Inflammation Research
- Respiratory Research
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Browse full report with TOC & List of Figures: https://www.imarcgroup.com/g-protein-coupled-receptors-market
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/